secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001193125-25-316225
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics terminates Yorkville equity facility; $3M drawn, no penalties
-------------------------------------------------------------------------------

- Terminated Pre-Paid Advance and Standby Equity Purchase Agreements with Yorkville on Dec 11, 2025.
- Total $3M in advances drawn under PPA; most recent advance on Oct 23, 2025.
- No sales of common stock executed under the Standby Equity Purchase Agreement.
- No penalties or fees incurred in connection with the termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525316225/0001193125-25-316225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525316225/d783815d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-316225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer